Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/ADIPS/APEG Working Group
Authors: Anthony J Pease, Sofianos Andrikopoulos, Mary B Abraham, Maria E Craig, Brett Fenton, Jane Overland, Sarah price, David Simmons and Glynis P Ross
A consensus statement on ‘Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes’ was jointly developed by a working group from representatives of the Australian Diabetes Society (ADS), the Australian Diabetes Educators Society (ADEA), the Australasian Paediatric Endocrine Group (APEG), and the Australasian Diabetes in Pregnancy Society (ADIPS) that reflects a national approach to provide best practice across the lifespan for all people living with type 1 diabetes, should have equitable access to the most effective diabetes management systems, including technology where clinically appropriate, regardless of age or concessional status. As diabetes management technologies continue to evolve, so too must management strategies and health care systems. The consensus recommendations should be read in conjunction with the Australian Living Evidence Guidelines in Diabetes.
The ADS/ADEA/APEG/ADIPS Consensus Statement on ‘Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes’ can be viewed via the Medicial Journal of Australia (MJA) webpage at Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group | The Medical Journal of Australia (mja.com.au) (Published online: 21 June, 2021). Download the consensus statement MJA summary – PDF (Posted: 21 June, 2021)
Please download the joint full version of the ADS/ADEA/APEG/ADIPS Consensus Statement on ‘Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes’ – PDF (Posted: 21 June, 2021). Please visit the Australian Living Evidence Guidelines in Diabetes webpage at ADS- Living Evidence Guidelines in Diabetes
